Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial.
Palmieri G, Buonerba C, Ottaviano M, Federico P, Calabrese F, Von Arx C, De Maio AP, Marino M, Lalle M, Montella L, Merola C, Milella M, Bergaglio M, Di Lorenzo G, Damiano V.
Palmieri G, et al. Among authors: von arx c.
Future Oncol. 2014 Nov;10(14):2141-7. doi: 10.2217/fon.14.144.
Future Oncol. 2014.
PMID: 25471029
Clinical Trial.